Cocrystal Pharma, Inc. (COCP)
NASDAQ: COCP · Real-Time Price · USD
2.250
+0.150 (7.14%)
At close: Dec 20, 2024, 4:00 PM
2.247
-0.003 (-0.13%)
After-hours: Dec 20, 2024, 6:44 PM EST
Cocrystal Pharma Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | - | - | - | - | 2.01 | 6.56 | |
| Revenue Growth (YoY) | - | - | - | - | -69.32% | - | |
| Cost of Revenue | 14.77 | 15.17 | 12.39 | 8.79 | 6.03 | 4 | |
| Gross Profit | -14.77 | -15.17 | -12.39 | -8.79 | -4.02 | 2.56 | |
| Selling, General & Admin | 5.55 | 5.99 | 5.75 | 5.43 | 5.57 | 4.86 | |
| Operating Expenses | 5.55 | 5.99 | 5.75 | 5.43 | 5.57 | 4.86 | |
| Operating Income | -20.31 | -21.16 | -18.14 | -14.22 | -9.59 | -2.3 | |
| Interest Expense | - | - | -0 | -0 | -0.01 | -0.02 | |
| Interest & Investment Income | 0.66 | 0.64 | - | - | - | - | |
| Currency Exchange Gain (Loss) | -0.05 | -0.07 | -0.02 | -0.01 | - | - | |
| Other Non Operating Income (Expenses) | - | - | 0.01 | 0.05 | -0.05 | 0.26 | |
| EBT Excluding Unusual Items | -19.7 | -20.58 | -18.15 | -14.19 | -9.65 | -2.07 | |
| Impairment of Goodwill | - | - | -19.09 | - | - | -46.1 | |
| Legal Settlements | 1 | 2.6 | -1.6 | - | - | - | |
| Pretax Income | -18.7 | -17.98 | -38.84 | -14.19 | -9.65 | -48.17 | |
| Net Income | -18.7 | -17.98 | -38.84 | -14.19 | -9.65 | -48.17 | |
| Net Income to Common | -18.7 | -17.98 | -38.84 | -14.19 | -9.65 | -48.17 | |
| Shares Outstanding (Basic) | 10 | 10 | 8 | 7 | 5 | 3 | |
| Shares Outstanding (Diluted) | 10 | 10 | 8 | 7 | 5 | 3 | |
| Shares Change (YoY) | 11.55% | 18.52% | 10.58% | 60.04% | 73.32% | 13.75% | |
| EPS (Basic) | -1.84 | -1.86 | -4.77 | -1.93 | -2.10 | -18.14 | |
| EPS (Diluted) | -1.84 | -1.86 | -4.77 | -1.93 | -2.10 | -18.14 | |
| Free Cash Flow | -16.72 | -14.78 | -21.51 | -12.77 | -10.07 | -1.71 | |
| Free Cash Flow Per Share | -1.64 | -1.53 | -2.64 | -1.73 | -2.19 | -0.64 | |
| Gross Margin | - | - | - | - | -199.60% | 39.00% | |
| Operating Margin | - | - | - | - | -475.97% | -35.09% | |
| Profit Margin | - | - | - | - | -479.05% | -733.84% | |
| Free Cash Flow Margin | - | - | - | - | -500.00% | -26.02% | |
| EBITDA | -20.18 | -20.97 | -17.95 | -14.03 | -9.43 | -2.21 | |
| EBITDA Margin | - | - | - | - | - | -33.59% | |
| D&A For EBITDA | 0.14 | 0.19 | 0.19 | 0.19 | 0.16 | 0.1 | |
| EBIT | -20.31 | -21.16 | -18.14 | -14.22 | -9.59 | -2.3 | |
| EBIT Margin | - | - | - | - | - | -35.09% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.